Year: 2021
Type: review
Abstract: Cell-based scaffold-free therapies seek to develop in vitro organotypic three-dimensional (3D) tissue-like surrogates, capitalising upon the inherent capacity of cells to create tissues with efficiency and sophistication that is still unparalleled by human-made devices. Although automation systems have been realised and (some) success stories have been witnessed over the years in clinical and commercial arenas, in vitro organogenesis is far from becoming a standard way of care. This limited technology transfer is largely attributed to scalability-associated costs, considering that the development of a borderline 3D implantable device requires very high number of functional cells and prolonged ex vivo culture periods. Herein, we critically discuss advancements and shortfalls of scaffold-free cell-based tissue engineering strategies, along with pioneering concepts that have the potential to transform regenerative and reparative medicine.
Source: npj Regenerative Medicine
Language: English
Subfield: Biomedical Engineering
Field: Engineering
Domain: Physical Sciences
Open Access status: gold
Estimated APC paid: $3,490
Awards: G1860609334, G2705673605, G3841754732, G434337789, CÚRAM - Centre for Research in Medical Devices, G5570691226, Tissue Engineered Nanoassemblies Advanced Biomimicry of Living Equivalents (Short Title: TENABLE), G7838417605, Engineering in vitro microenvironments for translation of cell-based therapies for tendon repair
OpenAlex ID: W3151658090
